Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Nguyen USDT, Rothman KJ, Demissie S, Jackson DJ, Lang JM, Ecker JL. Transfers among women intending a birth center delivery in the San Diego birth center study. J Midwifery Womens Health. 2009 Mar 1;54(2):104-10.
Clarkson T, Anthony MS, Hughes C. Estrogenic soybean isoflavones and chronic disease: risks and benefits. Trends Endocrinol Metab. 1995 Jan;6(1):11-6.